A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...

Monogenic forms of early onset severe childhood obesity (ie, presenting before the age of 5 years) can occur in the context ...

In the United States, obesity-related ischemic heart disease (IHD) mortality is increasing, with the highest rates seen among men, Blacks, and those in the Midwest, according to a study presented at ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

The overall rate of obesity-related heart disease deaths increased by 5.03% annually during the 21-year study period.

Vitamin D supplementation may help manage hypertension, particularly in older adults with overweight or obesity, a new study ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

A deep learning model can predict the risk for obesity for young children using only routinely collected electronic health ...

RFK Jr. wants Americans to eat healthier by fixing what he deems is a corrupt food ecosystem. But this flies in the face of ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Altimmune (NASDAQ:ALT) is in a good place right now, especially when you consider that the one drug it has in its pipeline is ...